Cutera Company Profile (NASDAQ:CUTR)

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

Cutera announced that its board has authorized a stock repurchase plan on Tuesday, August 8th 2017, which authorizes the company to repurchase $25,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to purchase up to 6.8% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company's management believes its stock is undervalued.

Cutera, Inc. (NASDAQ:CUTR) issued its quarterly earnings data on Monday, August, 7th. The company reported $0.13 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.03 by $0.10. The firm earned $36.40 million during the quarter, compared to analysts' expectations of $32.08 million. Cutera had a net margin of 5.07% and a return on equity of 11.64%. The firm's quarterly revenue was up 32.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.07 EPS. View Cutera's Earnings History.

4 analysts have issued 12 month price targets for Cutera's shares. Their predictions range from $32.00 to $39.00. On average, they anticipate Cutera's share price to reach $34.67 in the next year. View Analyst Ratings for Cutera.

Here are some recent quotes from research analysts about Cutera stock:

• 1. Maxim Group analysts commented, "At the Investor Day on 6/14/17, CUTR reiterated the 2Q17 and full-year 2017 guidance it originally introduced on May 1, 2017. During the Investor Day presentation, CUTR provided additional details on its five-year growth plan, highlighted by its projection of a tripling of its annual revenue to $360M in 2021, from $118M in 2016." (7/13/2017)
• 2. According to Zacks Investment Research, "Cutera Inc designs, develops, manufactures and markets the CoolGlide family of products for use in laser and other light-based aesthetic applications. The original CoolGlide CV provides permanent hair reduction on all skin types. The second generation CoolGlide Excel incorporated features that added the capability to treat a variety of vascular lesions, which include facial telangiectasia, spider and reticular leg veins. The CoolGlide Vantage added non-ablative skin therapy to the range of applications offered by the system. " (6/27/2017)

Some companies that are related to Cutera include Veeco Instruments (VECO), CEVA (CEVA), Instructure (INST), Benefitfocus (BNFT), Cellcom Israel (CEL), Analogic Corporation (ALOG), Liberty TripAdvisor Holdings (LTRPA), PROS Holdings (PRO), Internet Initiative Japan (IIJI), Universal Electronics (UEIC), ORBCOMM (ORBC), MTS Systems Corporation (MTSC), Cray (CRAY), Ultra Clean Holdings (UCTT), Vocera Communications (VCRA), Boingo Wireless (WIFI), Monotype Imaging Holdings (TYPE) and Radware (RDWR).

Cutera's management team includes the folowing people:

• J. Daniel Plants, Chairman of the Board
• James A. Reinstein, President, Chief Executive Officer, Director
• Darren W. Alch, Vice President, General Counsel, Secretary
• David B. Apfelberg M.D., Independent Director
• Gregory A Barrett, Independent Director
• Timothy J. O'Shea, Independent Director
• Clinton H. Severson, Independent Director
• Jerry P. Widman CPA, Independent Director

Cutera's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (8.76%), Dimensional Fund Advisors LP (5.00%), Gamco Investors INC. ET AL (4.16%), Vanguard Group Inc. (4.12%), Kennedy Capital Management Inc. (2.63%) and Lyon Street Capital LLC (2.57%). Company insiders that own Cutera stock include David A Gollnick, J Daniel Plants, Jerry P Widman, Kevin P Connors, Larry Laber, Miguel Pardos and Ronald J Santilli. View Institutional Ownership Trends for Cutera.

Cutera's stock was sold by a variety of institutional investors in the last quarter, including Lyon Street Capital LLC, Dimensional Fund Advisors LP, Menta Capital LLC, Acadian Asset Management LLC, Precept Management LLC, JPMorgan Chase & Co., Dalton Greiner Hartman Maher & Co. and Globeflex Capital L P. Company insiders that have sold Cutera stock in the last year include David A Gollnick, J Daniel Plants, Larry Laber, Miguel Pardos and Ronald J Santilli. View Insider Buying and Selling for Cutera.

Cutera's stock was acquired by a variety of institutional investors in the last quarter, including Kennedy Capital Management Inc., Stonepine Capital Management LLC, Summit Creek Advisors LLC, Ameriprise Financial Inc., EAM Investors LLC, Rice Hall James & Associates LLC, Russell Investments Group Ltd. and Parametric Portfolio Associates LLC. View Insider Buying and Selling for Cutera.

Shares of Cutera can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Cutera stock can currently be purchased for approximately $33.75.